Oral GLP-1 therapies are reshaping pharmaceutical drug delivery, especially peptide-based formulations that require strict environmental control. One of the most important examples is Rybelsus developed by Novo Nordisk, which highlights how sensitive oral peptide drugs are to moisture exposure during storage and distribution.
For pharmaceutical manufacturers, maintaining stability is no longer only about formulation—it is also about packaging performance.
Moisture Sensitivity in Oral Semaglutide
Oral semaglutide is a peptide-based compound, meaning it is inherently sensitive to environmental conditions such as humidity.
Moisture exposure may lead to:
reduced chemical stability
changes in dissolution performance
degradation of active ingredients
shortened shelf life
This makes moisture control a critical requirement in both development and commercialization stages.
Role of Desiccant Bottles in Stability Protection
Desiccant Bottle systems are designed to actively reduce humidity inside the container environment.
Compared to standard HDPE bottles, desiccant bottles provide:
Continuous moisture absorption
Lower internal humidity levels
Improved protection during storage and shipping
Enhanced long-term stability for sensitive drugs
For oral semaglutide tablets, this helps maintain consistent product quality from manufacturing to patient use.
ISO 15378 Manufacturing Advantage from Xinfuda
Xinfuda provides moisture-proof pharmaceutical packaging solutions manufactured under ISO 15378.
This is important for pharmaceutical companies because ISO 15378 ensures:
controlled production environment
traceability of packaging materials
risk-based quality management
compliance with pharmaceutical packaging standards
For oral GLP-1 products, regulatory expectations are increasingly strict, especially in FDA-regulated markets.
Why Combination of Desiccant Bottle + ISO 15378 Matters
The combination of desiccant technology and ISO 15378 manufacturing creates a complete packaging solution:
Desiccant bottle → controls internal humidity
ISO 15378 system → ensures pharmaceutical-grade quality control
High-barrier design → supports long-term stability
This integrated approach is especially relevant for:
oral peptide drugs
GLP-1 formulations
probiotics and sensitive nutraceuticals
effervescent tablets
Global Demand for Moisture-Proof Packaging
As oral biologics expand globally, pharmaceutical supply chains face increasing challenges such as:
high-humidity transportation environments
long-distance distribution
variable storage conditions
This is driving stronger demand for:
desiccant bottle systems
CRC moisture-control caps
pharmaceutical-grade HDPE packaging
Oral semaglutide represents a broader shift toward oral peptide and biologic therapies, where packaging plays a direct role in drug stability.
By combining desiccant bottle technology with ISO 15378-certified manufacturing systems, Xinfuda delivers moisture-proof pharmaceutical packaging solutions designed to support stability, compliance, and global distribution requirements.
As GLP-1 and oral peptide markets continue expanding, advanced moisture-control packaging will become a standard requirement rather than an optional upgrade.
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
MAKE AN ENQUIRY
